Ferrante Karen Jean
SEC-identified person · CIK 1598502 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Unum Therapeutics, Inc. UNUM | Director | filed 2018 - 2026 |
| Macrogenics INC MGNX | Director | filed 2017 - 2026 |
| Progenics Pharmaceuticals INC PGNX | Director | filed 2014 - 2020 |
| Baxalta Inc BXLT | Director | filed 2015 - 2016 |
| Tokai Pharmaceuticals Inc TKAI | Head Res. & Dev. & Chief Med. | filed 2014 - 2015 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.